Viewing Study NCT00879658

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:58 PM

Ignite Modification Date: 2025-12-25 @ 9:55 PM

Study NCT ID: NCT00879658

Status: COMPLETED

Last Update Posted: 2020-01-13

First Post: 2009-04-09

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Sponsor: Novartis Pharmaceuticals

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module